NSCLC cells with FXR/HVEM silencing or overexpression were cocultured with purified CD8+ T cells at a 1:25 target-to-effector cell ratio (Supplemental Figure 4, A and B), as described in our previous study (16). The gene discussed is NR1H4; the disease is non-small cell lung carcinoma.